Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Sees Significant Drop in Short Interest

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) saw a large decline in short interest in November. As of November 30th, there was short interest totalling 199,600 shares, a decline of 45.9% from the November 15th total of 368,900 shares. Based on an average daily volume of 618,300 shares, the short-interest ratio is currently 0.3 days.

Shionogi & Co., Ltd. Price Performance

Shares of OTCMKTS:SGIOY traded down $0.12 on Friday, reaching $7.03. 175,323 shares of the company were exchanged, compared to its average volume of 163,113. The company has a current ratio of 5.86, a quick ratio of 5.37 and a debt-to-equity ratio of 0.01. Shionogi & Co., Ltd. has a 1-year low of $6.22 and a 1-year high of $9.11. The company has a 50-day moving average of $6.96 and a 200-day moving average of $9.29. The firm has a market cap of $11.96 billion, a price-to-earnings ratio of 11.92, a price-to-earnings-growth ratio of 4.86 and a beta of 0.21.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.